Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

DNTHDNTH
5 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in Dianthus Therapeutics, Inc.

BAKER BROS. ADVISORS LP holds 852,164 shares of DNTH (Dianthus Therapeutics, Inc.), worth $83.1M as of 2026-Q2. DNTH represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$83.1M

Current Shares

852,164

Total Value Change

+$68.4M

Total Shares Change

+62,405

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
852,164
0.0%
$83.1M0.4%$97.48
0
2026-Q1
Increased
852,164
+7.9%
$71.5M0.4%$55.39
38
2025-Q4
Unchanged
789,759
0.0%
$32.5M0.2%$40.96
0
2025-Q3
Unchanged
789,759
0.0%
$31.1M0.2%$39.55
0
2025-Q2
New
789,759
-
$14.7M0.1%$17.63
46

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used